Back

Single-Cell Analysis Reveals Macrophage-Driven T Cell Dysfunction in Severe COVID-19 Patients

Liu, X.; Zhu, A.; He, J.; Chen, Z.; Liu, L.; Xu, Y.; Ye, F.; Feng, H.; Luo, L.; Cai, B.; Mai, Y.; Lin, L.; Zhang, Z.; Chen, S.; Shi, J.; Wen, L.; Wei, Y.; Zhuo, J.; Zhao, Y.; Li, F.; Wei, X.; Chen, D.; Zhang, X.; Zhong, N.; Huang, Y.; Liu, H.; Wang, J.; Xu, X.; Wang, J.; Chen, R.; Chen, X.; Zhong, N.; Zhao, J.; Li, Y.; Zhao, J.; Chen, J.

2020-05-26 pathology
10.1101/2020.05.23.20100024
Show abstract

The vastly spreading COVID-19 pneumonia is caused by SARS-CoV-2. Lymphopenia and cytokine levels are tightly associated with disease severity. However, virus-induced immune dysregulation at cellular and molecular levels remains largely undefined. Here, the leukocytes in the pleural effusion, sputum, and peripheral blood biopsies from severe and mild patients were analyzed at single-cell resolution. Drastic T cell hyperactivation accompanying elevated T cell exhaustion was observed, predominantly in pleural effusion. The mechanistic investigation identified a group of CD14+ monocytes and macrophages highly expressing CD163 and MRC1 in the biopsies from severe patients, suggesting M2 macrophage polarization. These M2-like cells exhibited up-regulated IL10, CCL18, APOE, CSF1 (M-CSF), and CCL2 signaling pathways. Further, SARS-CoV-2-specific T cells were observed in pleural effusion earlier than in peripheral blood. Together, our results suggest that severe SARS-CoV-2 infection causes immune dysregulation by inducing M2 polarization and subsequent T cell exhaustion. This study improves our understanding of COVID-19 pathogenesis.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
based on 483 papers
Top 3%
15.8%
2
The American Journal of Pathology
based on 11 papers
Top 0.2%
7.8%
3
Acta Neuropathologica
based on 11 papers
Top 0.1%
7.8%
4
Modern Pathology
based on 10 papers
Top 0.5%
5.5%
5
JCI Insight
based on 63 papers
Top 1%
5.2%
6
PLOS ONE
based on 1737 papers
Top 69%
4.8%
7
Journal of Clinical Pathology
based on 11 papers
Top 0.4%
4.6%
50% of probability mass above
8
European Respiratory Journal
based on 44 papers
Top 2%
3.0%
9
Cell Reports
based on 25 papers
Top 0.2%
3.0%
10
iScience
based on 74 papers
Top 1%
2.9%
11
mBio
based on 34 papers
Top 0.6%
2.6%
12
Cell
based on 28 papers
Top 0.9%
2.4%
13
Nature Medicine
based on 88 papers
Top 5%
2.3%
14
Brain
based on 69 papers
Top 5%
1.6%
15
Cells
based on 14 papers
Top 0.7%
1.6%
16
Scientific Reports
based on 701 papers
Top 76%
1.4%
17
Blood Advances
based on 16 papers
Top 0.8%
1.4%
18
Nature
based on 58 papers
Top 9%
0.8%
19
Clinical Infectious Diseases
based on 219 papers
Top 19%
0.8%
20
Cell Reports Medicine
based on 49 papers
Top 5%
0.8%
21
Frontiers in Medicine
based on 99 papers
Top 18%
0.8%
22
International Journal of Molecular Sciences
based on 39 papers
Top 3%
0.8%
23
EBioMedicine
based on 21 papers
Top 2%
0.7%
24
The Lancet Digital Health
based on 25 papers
Top 6%
0.7%
25
Science Immunology
based on 15 papers
Top 1%
0.7%
26
Biomedicines
based on 21 papers
Top 4%
0.7%
27
Journal of the American Society of Nephrology
based on 19 papers
Top 1%
0.7%
28
Journal of Experimental Medicine
based on 10 papers
Top 0.9%
0.7%
29
Nature Immunology
based on 14 papers
Top 1%
0.7%